Mitazalimab
米佐利单抗
Report date: 2026/05/07 20:00:36
Base Information
Drug NameMitazalimab
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications +[6]
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory +[9]
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesAlligator Bioscience Ab
China Registration ClassN/A
Develop Information
Active CompaniesAlligator Bioscience AbUniversity Of California San DiegoErasmus Medical Center +[5]
Inactive CompaniesN/A
Active Indications +[5]
Inactive Indications
Other Information
ATC CodeN/A
Related LinksDrugBank